SOURCE: Xtalks

Xtalks Webinars

September 30, 2015 07:00 ET

Accelerating Timelines From Candidate Selection to Proof-of-Concept With Enabled-FIH® Programs, New Webinar Hosted by Xtalks

TORONTO, ONTARIO--(Marketwired - September 30, 2015) - Proof-of-Concept (POC) is a pivotal milestone in the drug development process. Analysis of attrition data from the pharma industry indicates that around 80% of drug candidates continue to fail at, or prior to, POC and do not progress into the later stages of development. Consequently, the early development processes must be re-engineered to improve R&D productivity and shorten project timelines, whilst at the same time allowing a more flexible and interrogative investigation of a drug candidate's unique potential.

On Wednesday, October 14, 2015, featured speakers Alyson Connor, Executive Director of Exploratory Clinical Pharmacology at Quotient Clinical, and Hazel Hunt, VP of Research at Corcept Therapeutics, will discuss the Enabled-FIH approach designed specifically to address these requirements. There will be two live broadcasts, at 9am EDT (2pm BST/UK) and 12pm EDT.

This webinar will present a set of case studies that will illustrate:

  • Integrated and adaptive clinical protocols combining healthy volunteer and POC investigations
  • Inclusion of POC either at Quotient, or at other sites globally within a single clinical protocol
  • Real time adjustment of drug dose and product composition in response to emerging clinical data
  • Continuity of drug product supply to global clinical sites

Dr. Hunt will present the design and results of an early development program focused on a new molecule CORT125134, which is in development for the treatment of Cushing's syndrome and certain cancers, and Dr. Connor will present further cases studies illustrating the applications and benefits of Enabled-FIH.

To learn more about this event visit: Accelerating Timelines from Candidate Selection to Proof-of-Concept with Enabled-FIH® Programs

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/9/29/11G061941/Images/Logo-1088849224186.jpg

Contact Information